miLab
The miLab platform is an innovative POCT hematology system combining a compact analyzer with disposable cartridges for automated blood cell morphology analysis (BCMA). Its hydrogel-based stamping technology enables solution-free blood cell staining and imaging, eliminating the need for reagents or manual preparation. Studies have highlighted its potential in infectious disease contexts such as COVID-19, where blood cell morphology can inform treatment and prognosis. With quick training, simple operation, and cartridge-based workflow, miLab is positioned as a near-patient digital morphology solution for clinics, emergency settings, and decentralized labs. Please Log In to access Additional Details and documents .. System Concept miLab is a point-of-care diagnostic platform built around miLab Device + miLab Cartridge, designed for automated Blood Cell Morphology Analysis (BCMA). Uses hydrogel-based stamping technology for solution-free blood cell staining, enabling rapid and reagent-free slide preparation. Technology & Principles BCMA (Blood Cell Morphology Analysis): digital morphology analysis directly from whole blood. Automated cartridge-based workflow (sample-in, result-out). Hydrogel-stamping allows visualization of blood cell structures without additional reagents. Integrates optical imaging with AI-based analysis for morphology classification. Applications Hematology: near-patient morphology assessment of WBC, RBC, platelets. COVID-19 Prognosis: referenced in clinical studies as BCMA morphology changes can help guide prognostication and treatment of COVID-19 patients. Broad clinical settings: emergency care, infectious disease management, hematology follow-up. Workflow Uses a disposable miLab Cartridge for sample handling. No need for chemical stains or wet reagents. Designed for rapid, low-maintenance operation with minimal user steps. Supporting Evidence Reference video materials: Quick user guide (2 mins) Training video on device + cartridge usage (12 mins) Reference publication:Hydrogel-Based Stamping Technology for Solution-Free Blood Cell Staining (validating the core staining-free imaging approach). Reference thesis/publication: Demonstrates BCMA’s utility in guiding treatment decisions for COVID-19 patients. Advantages Portable & simple → suitable for bedside and decentralized testing. Eliminates chemical staining → safer, cleaner, and faster workflow. Cartridge-based, no cross-contamination. AI + imaging supports objective morphology reporting.
Compatible with whole blood samples.